Home

Christopher M Smith

CIK 1436707 · Chief Executive Officer · last filed 2026-06-04

Christopher M Smith is a Chief Executive Officer who has filed 25 SEC Form 4 insider transactions across 7 companies since 2008. The most recent filing, for PACB, was dated Jun 4, 2026. Across all open-market trades the lifetime net is −$8.0M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $11.8M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$11.85M

Companies

7

Total Filings

25

Lifetime Open-Market Net

-$8.00M

Filer Profile

Reported Address
3248 COUNTRY CLUB PARKWAY
CASTLE ROCK, CO 80108
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
PACB Director 54,099 $1.30 $70.3K $0 3 2026-06-04
NEO Chief Executive Officer 655,652 $17.32 $11.36M $0 7 2025-02-25
QDEL Director 35,577 $11.78 $419.1K $0 5 2023-06-08
Akouos, Inc. (AKUS) Delisted Director — $13.29 — $0 2 2022-06-27
Ortho Clinical Diagnostics Holdings plc (OCDX) Delisted Chairman and CEO 467,360 $17.63 $8.24M -$8.00M 2 2022-01-05
Startek, Inc. (SRT) Delisted Director 21,950 $4.42 $97.0K $0 3 2011-10-04
XTNT Director — $0.35 — $0 1 2008-06-19

Recent Filings

25 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-06-04 PACB Grant (A) — $0 EDGAR
2025-06-06 PACB Grant (A) — $0 EDGAR
2025-02-25 NEO Mixed +43,346 $0 EDGAR
2025-02-03 PACB Grant (A) +54,099 $0 EDGAR
2024-12-04 NEO Mixed +29,150 -$281.0K EDGAR
2024-08-19 NEO Tax (F) −33,130 $0 EDGAR
2024-05-14 NEO Mixed +77,213 -$281.0K EDGAR
2024-02-27 NEO Grant (A) — $0 EDGAR
2023-06-08 QDEL Mixed +2,248 $0 EDGAR
2023-05-31 QDEL Tax (F) −1,225 -$104.8K EDGAR
Showing 1–10 of 25
Page 1 of 3
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.